CSS LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,000
| Closed | -$1.58M | – | 1206 |
|
|
2025
Q1 | $1.58M | Buy |
+12,000
| New | +$1.5M | 0.09% | 179 |
|
|
2023
Q1 | – | Sell |
-43,200
| Closed | -$2.29M | – | 934 |
|
|
2022
Q4 | $2.29M | Buy |
43,200
+31,300
| +263% | +$1.57M | 0.13% | 157 |
|
|
2022
Q3 | $554K | Sell |
11,900
-45,600
| -79% | -$2.38M | 0.03% | 489 |
|
|
2022
Q2 | $3.28M | Buy |
57,500
+6,400
| +13% | +$363K | 0.13% | 178 |
|
|
2022
Q1 | $3.13M | Buy |
51,100
+8,100
| +19% | +$421K | 0.11% | 176 |
|
|
2021
Q4 | $2.25M | Buy |
+43,000
| New | +$1.81M | 0.08% | 226 |
|
|
2021
Q2 | – | Sell |
-6,000
| Closed | -$204K | – | 1193 |
|
|
2021
Q1 | $204K | Buy |
+6,000
| New | +$208K | 0.01% | 769 |
|
|
2020
Q4 | – | Sell |
-14,200
| Closed | -$365K | – | 963 |
|
|
2020
Q3 | $365K | Sell |
14,200
-11,000
| -44% | -$251K | 0.02% | 472 |
|
|
2020
Q2 | $647K | Buy |
+25,200
| New | +$510K | 0.04% | 340 |
|
|
2020
Q1 | – | Sell |
-27,400
| Closed | -$941K | – | 784 |
|
|
2019
Q4 | $941K | Buy |
+27,400
| New | +$329K | 0.05% | 260 |
|
Other funds holding ITCI
KIM
HNB